Jaskoll T, Choy H A, Melnick M
Laboratory for Developmental Genetics, University of Southern California, Los Angeles 90089-0641.
J Craniofac Genet Dev Biol. 1994 Oct-Dec;14(4):217-30.
Branching morphogenesis is a fundamental embryologic process in many developing organs: salivary gland, lung, pancreas, mammary gland, and kidney. Glucocorticoids (CORT) are known to regulate morphogenesis in several branching organs (e.g., lung); we hypothesize that CORT is also important to embryonic mouse salivary gland morphogenesis. We studied the CORT-glucocorticoid receptor (GR) signal transduction pathway during embryonic mouse submandibular gland development. Western analysis demonstrates that the 96-kDa GR is present in E14 to E18 submandibular glands. The embryonic GR is functional, as defined by its ability to bind a DNA CORT response element, for all gestational ages evaluated (E14 to E18); increasing GR levels are observed with progressive development. The level of endogenous corticosterone in embryonic submandibular glands was also determined. Using radioimmunoassays corticosterone is first detected on day 15 of gestation; there is a progressive increase in steroid levels from day 15 to 18 of gestation. In addition, we investigated the effect of exogenous CORT on submandibular gland morphogenesis in vivo and in vitro. In vivo experiments were performed using maternal injection of CORT or sham injection on day 12 of gestation with sacrifice 72 hr post-injection (E15). CORT treatment significantly increases embryonic submandibular gland growth in vivo. To further analyze the effect of exogenous CORT on embryonic submandibular gland morphogenesis, E13 mouse submandibular glands were cultured under serum-free, chemically-defined conditions. A significant (P < 0.05) enhancement of mean branching ratios (72 hr/0 hr) is detected in CORT-supplemented explants (10(-5) M to 10(-8) M) compared to control explants; doses more dilute than 10(-8) M CORT do not significantly (P > 0.10) increase the induction of branching. In addition, CORT administration to embryonic mice in utero enhances the expression of acinar-cell-specific mucin protein. These data indicate that the CORT-GR signal transduction pathway plays an important role in salivary gland morphogenesis. Northern analysis of TGF-beta 1, TGF-beta 2, and TGF-beta 3 transcript levels in vivo confirms the presence of TGF-beta 1 and TGF-beta 2 and identifies TGF-beta 3 in embryonic submandibular glands. To begin to identify a molecular mechanism of CORT-GR mediated submandibular gland morphodifferentiation, we studied the effect of CORT on growth factor gene expression, specifically TGF-beta. Northern analysis suggests that the CORT-GR signal transduction pathway modulates the rate of morphogenesis by regulating TGF-beta 2 and TGF-beta 3 mRNA expression.
分支形态发生是许多发育器官(如唾液腺、肺、胰腺、乳腺和肾脏)中的一个基本胚胎学过程。已知糖皮质激素(CORT)可调节多个分支器官(如肺)的形态发生;我们推测CORT对胚胎小鼠唾液腺的形态发生也很重要。我们研究了胚胎小鼠下颌下腺发育过程中的CORT-糖皮质激素受体(GR)信号转导途径。蛋白质免疫印迹分析表明,96-kDa的GR存在于胚胎第14至18天的下颌下腺中。在所评估的所有胎龄(胚胎第14至18天)中,胚胎GR都具有功能,这是由其结合DNA CORT反应元件的能力所定义的;随着发育进程,GR水平不断升高。我们还测定了胚胎下颌下腺中内源性皮质酮的水平。使用放射免疫分析法,在妊娠第15天首次检测到皮质酮;从妊娠第15天到18天,类固醇水平逐渐升高。此外,我们研究了外源性CORT在体内和体外对下颌下腺形态发生的影响。体内实验是通过在妊娠第12天对母体注射CORT或假注射,并在注射后72小时(胚胎第15天)处死动物来进行的。CORT处理显著增加了胚胎下颌下腺在体内的生长。为了进一步分析外源性CORT对胚胎下颌下腺形态发生的影响,将胚胎第13天的小鼠下颌下腺在无血清、化学成分明确的条件下进行培养。与对照外植体相比,在添加CORT的外植体(10⁻⁵ M至10⁻⁸ M)中检测到平均分支率(72小时/0小时)有显著(P < 0.05)提高;比10⁻⁸ M更稀的CORT剂量不会显著(P > 0.10)增加分支诱导。此外,对子宫内的胚胎小鼠给予CORT可增强腺泡细胞特异性粘蛋白的表达。这些数据表明,CORT-GR信号转导途径在唾液腺形态发生中起重要作用。对体内TGF-β1、TGF-β2和TGF-β3转录水平的Northern分析证实了胚胎下颌下腺中存在TGF-β1和TGF-β2,并鉴定出了TGF-β3。为了开始确定CORT-GR介导的下颌下腺形态分化的分子机制,我们研究了CORT对生长因子基因表达,特别是TGF-β的影响。Northern分析表明,CORT-GR信号转导途径通过调节TGF-β2和TGF-β3 mRNA的表达来调节形态发生的速率。